Stock listing
OTC:CHEOY Cochlear Limited Stock
US listing (OTC) of Cochlear Limited · home listing ASX:COH
Follow Cochlear Limited into a list and get an email when it puts out news.
Share price · OTC:CHEOY
$49.12 USD -1.72 (-3.4%)
Close on Nov 20, 2026
- Day range
- $49.12 – $50.00 USDNov 20, 2026
- Volume
- 800 sharesNov 20, 2026
- Market cap
- $6.42B USDAt the close on Nov 20, 2026 · price × 130.8M shares outstanding
- 52-week range
- $32.14 – $96.56 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $976,507 USDMedian day 14,873 shares · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:COH · Home | $149.99 AUD | -3.18 (-2.1%) | 223,396 | $153.65 | $153.68 | $147.63 | $153.17 | Close on Nov 20, 2026 |
| OTC:CHEOY | $49.12 USD | -1.72 (-3.4%) | 800 | $49.75 | $50.00 | $49.12 | $50.84 | Close on Nov 20, 2026 |
| OTC:CHEOF | $100.00 USD | +2.43 (+2.5%) | 751 | $100.00 | $100.00 | $100.00 | $97.57 | Close on Nov 19, 2026 |
| Frankfurt:OC5 | €89.84 EUR | -3.62 (-3.9%) | 36 | €90.74 | €90.74 | €89.84 | €93.46 | Close on Nov 20, 2026 |
| Munich:OC5 | €90.51 EUR | -3.18 (-3.4%) | — | €91.13 | €91.13 | €90.51 | €93.69 | Close on Nov 20, 2026 |
| Frankfurt:OC50 | €45.60 EUR | -1.00 (-2.1%) | — | €45.60 | €45.60 | €45.60 | €46.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · OTC:CHEOY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $53.14 | +0.57 | +1.1% | $53.00 | $53.39 | $53.00 | 3,400 | |
| $52.57 | +2.48 | +5.0% | $54.00 | $54.00 | $52.57 | 13,600 | |
| $50.09 | +0.99 | +2.0% | $50.01 | $50.45 | $50.01 | 32,200 | |
| $49.10 | -0.21 | -0.4% | $49.36 | $49.40 | $49.10 | 6,800 | |
| $49.31 | -0.95 | -1.9% | $49.33 | $49.53 | $49.30 | 7,600 | |
| $50.26 | +0.42 | +0.8% | $49.18 | $50.31 | $49.18 | 3,200 | |
| $49.84 | +0.44 | +0.9% | $50.88 | $50.88 | $49.77 | 22,500 | |
| $49.40 | +0.32 | +0.7% | $49.41 | $50.05 | $49.19 | 11,900 | |
| $49.08 | -0.47 | -0.9% | $49.82 | $49.82 | $48.85 | 9,200 | |
| $49.55 | -1.86 | -3.6% | $49.75 | $50.48 | $49.27 | 4,000 | |
| $51.41 | +2.29 | +4.7% | $51.24 | $51.42 | $51.00 | 14,700 | |
| $49.12 | -0.44 | -0.9% | $49.12 | $49.22 | $49.00 | 14,200 | |
| $49.56 | +0.697 | +1.4% | $49.57 | $49.76 | $49.48 | 10,400 | |
| $48.86 | +2.573 | +5.6% | $48.86 | $48.86 | $48.86 | 29,345 | |
| $46.29 | +0.85 | +1.9% | $46.29 | $46.29 | $46.29 | 26,061 | |
| $45.44 | +0.72 | +1.6% | $43.84 | $46.04 | $43.84 | 29,200 | |
| $44.72 | -0.03 | -0.1% | $44.61 | $44.82 | $44.60 | 26,700 | |
| $44.75 | -0.30 | -0.7% | $44.90 | $45.16 | $44.72 | 14,900 | |
| $45.05 | +0.21 | +0.5% | $43.38 | $46.89 | $43.38 | 46,800 | |
| $44.84 | +0.20 | +0.4% | $45.79 | $46.08 | $44.80 | 14,000 | |
| $44.64 | -0.18 | -0.4% | $44.80 | $44.86 | $44.55 | 9,000 | |
| $44.82 | -0.25 | -0.6% | $45.20 | $45.22 | $44.50 | 20,700 | |
| $45.07 | -0.378 | -0.8% | $45.84 | $45.84 | $44.89 | 40,500 | |
| $45.45 | -0.071 | -0.2% | $45.45 | $45.45 | $45.45 | 30,825 | |
| $45.52 | +1.939 | +4.4% | $45.52 | $45.52 | $45.52 | 28,509 | |
| $43.58 | -1.71 | -3.8% | $43.72 | $43.72 | $43.50 | 14,500 | |
| $45.29 | -2.50 | -5.2% | $45.29 | $45.30 | $44.94 | 21,800 | |
| $47.79 | -2.37 | -4.7% | $48.58 | $48.58 | $47.79 | 18,600 | |
| $50.16 | -0.72 | -1.4% | $50.55 | $50.55 | $50.10 | 4,100 | |
| $50.88 | +0.98 | +2.0% | $50.84 | $51.67 | $50.82 | 12,600 | |
| $49.90 | +0.11 | +0.2% | $49.48 | $50.08 | $49.48 | 17,400 | |
| $49.79 | +0.72 | +1.5% | $50.02 | $50.02 | $49.62 | 31,500 | |
| $49.07 | -1.00 | -2.0% | $48.98 | $49.38 | $48.96 | 12,800 | |
| $50.07 | -0.29 | -0.6% | $49.50 | $50.15 | $49.50 | 11,500 | |
| $50.36 | +2.765 | +5.8% | $50.31 | $50.41 | $50.25 | 25,200 | |
| $47.60 | -0.909 | -1.9% | $47.60 | $47.60 | $47.60 | 12,384 | |
| $48.50 | -0.432 | -0.9% | $48.50 | $48.50 | $48.50 | 20,029 | |
| $48.94 | +0.295 | +0.6% | $48.94 | $48.94 | $48.94 | 9,756 | |
| $48.64 | +0.027 | +0.1% | $48.64 | $48.64 | $48.64 | 16,088 | |
| $48.61 | +0.505 | +1.0% | $48.61 | $48.61 | $48.61 | 25,782 | |
| $48.11 | -1.20 | -2.4% | $48.11 | $48.11 | $48.11 | 8,679 | |
| $49.31 | +0.391 | +0.8% | $49.31 | $49.31 | $49.31 | 19,773 | |
| $48.92 | -1.513 | -3.0% | $48.92 | $48.92 | $48.92 | 16,689 | |
| $50.43 | -0.977 | -1.9% | $50.43 | $50.43 | $50.43 | 8,623 | |
| $51.41 | +0.704 | +1.4% | $51.41 | $51.41 | $51.41 | 4,031 | |
| $50.70 | +1.79 | +3.7% | $50.70 | $50.70 | $50.70 | 16,394 | |
| $48.91 | +0.847 | +1.8% | $48.91 | $48.91 | $48.91 | 23,925 | |
| $48.07 | +0.08 | +0.2% | $48.07 | $48.07 | $48.07 | 104,335 | |
| $47.99 | -0.91 | -1.9% | $47.99 | $47.99 | $47.99 | 106,025 | |
| $48.90 | -0.638 | -1.3% | $48.90 | $48.90 | $48.90 | 25,139 | |
| $49.54 | +0.197 | +0.4% | $49.54 | $49.54 | $49.54 | 13,269 | |
| $49.34 | +0.015 | 0.0% | $49.34 | $49.34 | $49.34 | 14,845 | |
| $49.32 | +0.755 | +1.6% | $49.32 | $49.32 | $49.32 | 19,415 | |
| $48.57 | +0.039 | +0.1% | $48.57 | $48.57 | $48.57 | 11,998 | |
| $48.53 | -0.203 | -0.4% | $48.53 | $48.53 | $48.53 | 11,414 | |
| $48.73 | -0.15 | -0.3% | $48.73 | $48.73 | $48.73 | 11,367 |
- Ticker
- OTC:CHEOY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Notification regarding unquoted securities - COH
Latest earnings call · Aug 18, 2026
Cochlear (ASX:COH) Q4 2026 Earnings Call
Replay and transcript
Latest deck · Nov 13, 2026
Investor Day (November 2026)
Investor day · 132 slides
Latest news
2026 AGM Results
Oct 25, 2026
Closed $49.55 (-3.6%) on Oct 26, 2026
2026 AGM Chair and CEO & President Addresses
Oct 25, 2026
Closed $49.55 (-3.6%) on Oct 26, 2026
Ceasing to be a substantial holder
Oct 22, 2026
Closed $49.12 (-0.9%) on Oct 22, 2026
Notification of cessation of securities - COH
Oct 13, 2026
Closed $44.75 (-0.7%) on Oct 14, 2026
Change in substantial holding
Oct 5, 2026
Closed $45.45 (-0.2%) on Oct 6, 2026
Defence of Class Action Proceedings
Sep 28, 2026
Closed $50.16 (-1.4%) on Sep 29, 2026
Cochlear Limited on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 68 in the last 12 months · 184 in all · newest Nov 17, 2026 · oldest 2016
- Calls
- 8 calls with a replay · 8 with a transcript · latest Aug 18, 2026
- Decks
- 86 decks · latest Nov 13, 2026
Where Cochlear Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:COH · Home listing | ASX | Australia | AUD |
| OTC:CHEOY · This page | OTC | United States | USD |
| OTC:CHEOF | OTC | United States | USD |
| gettex:OC5 | gettex | Germany | EUR |
| Tradegate:OC5 | Tradegate | Germany | EUR |
| LS Exchange:898321 | LS Exchange | Germany | EUR |
| Lang & Schwarz:898321 | Lang & Schwarz | Germany | EUR |
| Frankfurt:OC5 | Frankfurt | Germany | EUR |
| gettex:OC50 | gettex | Germany | EUR |
| BMV:COHN | BMV | Mexico | MXN |
| Munich:OC5 | Munich | Germany | EUR |
| BIVA:COHN | BIVA | Mexico | MXN |
| BX Swiss:OC5 | BX Swiss | Switzerland | CHF |
| Dusseldorf:OC5 | Dusseldorf | Germany | EUR |
| Dusseldorf:OC50 | Dusseldorf | Germany | EUR |
| Frankfurt:OC50 | Frankfurt | Germany | EUR |
| Hamburg:OC5 | Hamburg | Germany | EUR |
| Lang & Schwarz:A1C3B8 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1C3B8 | LS Exchange | Germany | EUR |
| Munich:OC50 | Munich | Germany | EUR |
| Stuttgart:OC5 | Stuttgart | Germany | EUR |
Valuation
P/E 66.6× against a median of 28.6×: 10th lowest of 11 Medical devices & supplies companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $9.83B AUD
- P/E
- 66.6×
- EV/sales
- 4.2×
- EV/EBITDA
- 24.2×
- Price/book
- 5.6×
- Gross margin
- 70.5%
- Operating margin
- 12.9%
- Net margin
- 6.3%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cochlear Limited · ASX:COH | US$6.49B | US$6.51B | 66.6× | 4.2× | 24.2× | 5.6× | 6.3% | 0.1× | n/a |
| Globus Medical, Inc. · NYSE:GMED | US$7.48B | US$7.07B | 13.4× | 2.3× | 7.4× | 1.6× | 17.8% | 0.0× | 0.89 |
| Getinge AB Class B · OMXSTO:GETI_B | US$6.88B | US$7.67B | 24.9× | 2.3× | 11.2× | 2.1× | 8.2% | 0.3× | n/a |
| Teleflex Incorporated · NYSE:TFX | US$6.85B | US$8.04B | 22.5× | 3.6× | 20.1× | 2.0× | 13.5% | 0.5× | 0.50 |
| Ypsomed Holding AG · SIX:YPSN | US$6.80B | US$6.76B | 25.7× | 7.8× | 17.3× | 7.2× | 30.4% | 0.0× | n/a |
| ConvaTec Group PLC · LSE:CTEC | US$6.64B | US$8.29B | 37.9× | 3.4× | 15.2× | 4.6× | 7.2% | 1.2× | n/a |
| APT Medical Inc. Class A · SSE:688617 | US$5.98B | US$5.72B | 39.3× | 12.4× | n/a | 11.8× | 33.0% | 0.0× | n/a |
| Haemonetics Corporation · NYSE:HAE | US$5.47B | US$6.35B | 52.7× | 4.6× | 22.1× | 6.1× | 7.5% | 1.3× | 0.27 |
| Merit Medical Systems, Inc. · NASDAQ:MMSI | US$5.05B | US$5.29B | 31.6× | 3.3× | 15.4× | 2.9× | 9.9% | 0.4× | 0.49 |
| LivaNova PLC · NASDAQ:LIVN | US$5.00B | US$4.73B | 25.5× | 3.1× | 21.6× | 3.6× | 13.0% | 0.2× | 1.02 |
| Intco Medical Technology Co., Ltd. Class A · SZSE:300677 | US$4.73B | US$3.55B | 106× | 1.8× | n/a | 1.7× | 2.3% | 0.0× | n/a |
| Median of the others | US$6.31B | US$6.55B | 28.6× | 3.3× | 16.4× | 3.3× | 11.5% | 0.3× | 0.50 |
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 136.34 AUD · Analysts' mean
- EPS, year to Jun 2027
- 5.20 · 16 analysts
- Revenue, year to Jun 2027
- 2.37B · 16 analysts
Events
- Next results
- Feb 12, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Cochlear (ASX:COH) Q4 2026 Earnings Call | Mon, Aug 17, 2026 · 10:00 PM ET | Replay |
| Cochlear (ASX:COH) Q2 2026 Earnings Call | Fri, Feb 13, 2026 · 3:00 AM ET | Replay |
| Cochlear (ASX:COH) Q4 2025 Earnings Call | Thu, Aug 14, 2025 · 8:00 PM ET | Replay |
| Cochlear (ASX:COH) Q2 2025 Earnings Call | Thu, Feb 13, 2025 · 6:00 PM ET | Replay |
| Cochlear (ASX:COH) Q4 2024 Earnings Call | Wed, Aug 14, 2024 · 8:00 PM ET | Replay |
| Cochlear (ASX:COH) Q2 2024 Earnings Call | Sun, Feb 18, 2024 · 6:00 PM ET | Replay |
| Cochlear (ASX:COH) Q4 2023 Earnings Call | Mon, Aug 14, 2023 · 8:00 PM ET | Replay |
| Cochlear (ASX:COH) Q2 2023 Earnings Call | Tue, Feb 14, 2023 · 6:00 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Feb 13, 2026 | −18.4% |
| Q4 2025 | Aug 15, 2025 · Before open | +1.0% |
| Q2 2025 | Feb 13, 2025 | −14.3% |
| Q2 2023 | Feb 15, 2023 · Before open | +7.8% |
| Q4 2022 | Aug 19, 2022 | +2.9% |
| Q2 2022 | Feb 22, 2022 | +14.6% |
| Q4 2021 | Aug 20, 2021 | −5.7% |
| Q2 2021 | Feb 19, 2021 | +7.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (November 2026) | Investor day | 132 slides | Nov 13, 2026 |
| Investor Day (November 2026) | Investor day | 134 slides | Nov 13, 2026 |
| Cochlear Plc Ord — FY2026 Earnings Presentation | Earnings | 36 slides | Aug 18, 2026 |
| Cochlear Plc Ord — HY26 Earnings Presentation | Earnings | 27 slides | Feb 13, 2026 |
| FY2025 Earnings Presentation | Earnings | 37 slides | Aug 15, 2025 |
| Cochlear Plc Ord — HY25 Earnings Presentation | Earnings | 26 slides | Feb 14, 2025 |
| Cochlear Plc Ord — FY2024 Earnings Presentation | Earnings | 33 slides | Aug 15, 2024 |
| H1 FY2024 Earnings Presentation | Earnings | 26 slides | Feb 19, 2024 |
| Investor Day (October 2023) | Investor day | 115 slides | Oct 27, 2023 |
| Investor Day (October 2023) | Investor day | 114 slides | Oct 27, 2023 |
Show 50 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2023 Earnings Presentation | Earnings | 34 slides | Aug 15, 2023 |
| H1 FY2023 Earnings Presentation | Earnings | 39 slides | Feb 15, 2023 |
| FY2022 Earnings Presentation | Earnings | 45 slides | Aug 19, 2022 |
| H1 FY2022 Earnings Presentation | Earnings | 48 slides | Feb 22, 2022 |
| Shareholder Meeting (October 2021) | Shareholder meeting | 25 slides | Oct 19, 2021 |
| FY2021 Earnings Presentation | Earnings | 49 slides | Aug 20, 2021 |
| H1 FY2021 Earnings Presentation | Earnings | 28 slides | Feb 19, 2021 |
| Shareholder Meeting (October 2020) | Shareholder meeting | 29 slides | Oct 20, 2020 |
| FY2020 Earnings Presentation | Earnings | 36 slides | Aug 18, 2020 |
| Investor Presentation (March 2020) | Investor deck | 35 slides | Mar 25, 2020 |
| H1 2020 Earnings Presentation | Earnings | 28 slides | Feb 18, 2020 |
| Shareholder Meeting (October 2019) | Shareholder meeting | 22 slides | Oct 22, 2019 |
| Investor Day (May 2019) | Investor day | 55 slides | May 10, 2019 |
| H1 FY2019 Earnings Presentation | Earnings | 21 slides | Feb 19, 2019 |
| Shareholder Meeting (October 2018) | Shareholder meeting | 17 slides | Oct 16, 2018 |
| FY2018 Earnings Presentation | Earnings | 10 slides | Aug 14, 2018 |
| Investor Day (May 2018) | Investor day | 54 slides | May 4, 2018 |
| HY18 Earnings Presentation | Earnings | 11 slides | Feb 13, 2018 |
| Shareholder Meeting (October 2017) | Shareholder meeting | 19 slides | Oct 17, 2017 |
| FY2017 Earnings Presentation | Earnings | 13 slides | Aug 17, 2017 |
| Investor Day (May 2017) | Investor day | 65 slides | May 4, 2017 |
| HY17 Earnings Presentation | Earnings | 11 slides | Feb 14, 2017 |
| Shareholder Meeting (October 2016) | Shareholder meeting | 23 slides | Oct 18, 2016 |
| FY2016 Earnings Presentation | Earnings | 12 slides | Aug 9, 2016 |
| Investor Day (April 2016) | Investor day | 54 slides | Apr 28, 2016 |
| H1 2016 Earnings Presentation | Earnings | 12 slides | Feb 11, 2016 |
| Shareholder Meeting (October 2015) | Shareholder meeting | 30 slides | Oct 20, 2015 |
| FY2015 Earnings Presentation | Earnings | 16 slides | Aug 11, 2015 |
| H1 FY2015 Earnings Presentation | Earnings | 16 slides | Feb 10, 2015 |
| Shareholder Meeting (October 2014) | Shareholder meeting | 29 slides | Oct 14, 2014 |
| FY2014 Earnings Presentation | Earnings | 17 slides | Aug 5, 2014 |
| H1 FY2014 Earnings Presentation | Earnings | 16 slides | February 2014 |
| Shareholder Meeting (October 2013) | Shareholder meeting | 23 slides | Oct 15, 2013 |
| FY2013 Earnings Presentation | Earnings | 17 slides | Aug 6, 2013 |
| UBS Australian Healthcare Conference 2013 | Conference | 22 slides | Jun 17, 2013 |
| H1 FY2013 Earnings Presentation | Earnings | 15 slides | Feb 5, 2013 |
| Shareholder Meeting (October 2012) | Shareholder meeting | 24 slides | Oct 16, 2012 |
| FY2012 Earnings Presentation | Earnings | 32 slides | Aug 7, 2012 |
| H1 FY2012 Earnings Presentation | Earnings | 31 slides | Feb 7, 2012 |
| Shareholder Meeting (October 2011) | Shareholder meeting | 25 slides | Oct 18, 2011 |
This page holds 50 of 86 decks. Open Decks
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.33B | 2.34B | 2.24B | 1.94B | 1.64B | 1.49B | 1.35B | 1.43B | 1.36B | 1.25B |
| Cost of revenue | 688.0M | 615.2M | 562.1M | 488.0M | 411.0M | 410.2M | 355.9M | 351.1M | 361.2M | 358.4M |
| Gross profit | 1.65B | 1.73B | 1.67B | 1.47B | 1.23B | 1.08B | 1.01B | 1.08B | 1.00B | 895.4M |
| Research and development | 323.2M | 291.5M | 277.0M | 244.9M | 210.7M | 195.0M | 185.1M | 184.4M | 167.7M | 151.9M |
| Selling, general and administrative | 1.02B | 207.9M | 212.6M | 203.9M | 159.0M | 116.1M | 93.8M | 94.8M | 97.4M | 85.2M |
| Operating income | 301.0M | 406.1M | 521.5M | 389.5M | 361.7M | 327.9M | 259.0M | 352.9M | 345.2M | 315.2M |
| Depreciation and amortization | 106.0M | 90.4M | 84.9M | 80.9M | 73.0M | 76.4M | 77.5M | 38.5M | 34.2M | 31.2M |
| EBITDA | 407.0M | 496.5M | 606.4M | 470.4M | 434.7M | 404.3M | 336.5M | 391.4M | 379.4M | 346.4M |
| Interest expense | 13.2M | 11.0M | 9.20M | 9.40M | 8.60M | 12.0M | 10.5M | 5.20M | 8.50M | 7.52M |
| Income before tax | 201.0M | 518.5M | 484.8M | 396.8M | 393.8M | 363.5M | -269.9M | 365.6M | 340.5M | 308.8M |
| Income tax | 53.7M | 129.6M | 128.0M | 96.0M | 104.7M | 38.0M | -32.8M | 88.9M | 94.7M | 85.2M |
| Net income | 147.3M | 388.9M | 356.8M | 300.6M | 289.1M | 326.5M | -238.3M | 276.7M | 245.8M | 223.6M |
| Earnings per share, basic | 2.25 | 5.94 | 5.43 | 4.56 | 4.40 | 4.97 | -4.00 | 4.79 | 4.27 | 3.89 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 187.7M | 275.7M | 513.6M | 555.5M | 629.3M | 609.6M | 565.0M | 78.6M | 61.5M | 89.5M |
| Short-term investments | 102.7M | 90.8M | 68.8M | 27.3M | 365.0M | 365.0M | 3.70M | 18.4M | ||
| Receivables | 559.2M | 585.9M | 490.7M | 457.5M | 390.4M | 296.3M | 304.9M | 331.9M | 316.7M | 299.4M |
| Inventory | 491.3M | 499.4M | 391.6M | 311.5M | 270.2M | 216.1M | 223.8M | 195.4M | 167.4M | 160.0M |
| Current assets | 1.30B | 1.42B | 1.45B | 1.36B | 1.33B | 1.23B | 1.48B | 635.0M | 584.2M | 585.9M |
| Property, plant and equipment | 536.2M | 517.2M | 447.2M | 439.2M | 428.5M | 438.8M | 166.5M | 128.4M | 120.1M | |
| Goodwill | 265.6M | 278.6M | 257.7M | 256.1M | 257.1M | 267.3M | 270.9M | 268.8M | 265.4M | 267.1M |
| Total assets | 2.60B | 2.83B | 2.75B | 2.57B | 2.47B | 2.43B | 2.58B | 1.38B | 1.16B | 1.14B |
| Accounts payable | 270.6M | 298.4M | 303.2M | 270.4M | 232.4M | 202.9M | 159.3M | 160.8M | 140.5M | 130.9M |
| Current liabilities | 604.5M | 602.3M | 631.5M | 578.0M | 527.6M | 402.5M | 817.5M | 359.5M | 287.7M | 346.6M |
| Long-term debt | 0 | 45.0M | 79.9M | 178.3M | 144.0M | 134.2M | ||||
| Total debt | 212.7M | 235.7M | 243.7M | 201.8M | 253.9M | 264.3M | 704.5M | 181.6M | 147.7M | 218.9M |
| Total liabilities | 862.4M | 874.7M | 904.6M | 819.9M | 779.4M | 736.5M | 1.18B | 653.3M | 546.1M | 592.7M |
| Shareholders' equity | 1.74B | 1.95B | 1.84B | 1.75B | 1.69B | 1.69B | 1.40B | 725.9M | 610.8M | 543.6M |
| Shares outstanding | 65.5M | 65.4M | 65.7M | 65.9M | 65.8M | 65.7M | 59.6M | 57.7M | 57.6M | 57.5M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 368.0M | 237.6M | 388.8M | 362.4M | 376.5M | 265.4M | -157.8M | 296.0M | 258.1M | 259.8M |
| Capital spending | -61.1M | -62.4M | -62.4M | -95.9M | -77.2M | -66.7M | -130.5M | -59.9M | -28.4M | -53.5M |
| Free cash flow | 306.9M | 175.2M | 326.4M | 266.5M | 299.3M | 198.7M | -288.3M | 236.1M | 229.7M | 206.3M |
| Cash from investing | -104.5M | -115.2M | -105.7M | -125.7M | -138.9M | 279.9M | -509.7M | -137.8M | -55.4M | -135.6M |
| Cash from financing | -344.1M | -366.9M | -323.8M | -310.4M | -220.7M | -495.1M | 1.15B | -140.9M | -232.7M | -108.3M |
| Dividends paid | -281.2M | -278.2M | -245.7M | -197.4M | -194.0M | -75.6M | -193.7M | -181.8M | -161.1M | -143.5M |
| Share buybacks | -26.7M | -52.6M | -45.8M | -29.6M | -1.10M | 399.0M | 219.4M | 398.2M | -400.0K | 184.0M |
| Change in cash | -88.0M | -237.9M | -41.9M | -73.8M | 19.7M | 44.6M | 486.4M | 17.1M | -28.0M | 14.1M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Appendix 3Y - Michael del Prado | Nov 17, 2026 | Other filings | ASX |
| Appendix 3Y - Diggory Howitt | Nov 17, 2026 | Other filings | ASX |
| Notification regarding unquoted securities - COH | Nov 17, 2026 | Other filings | ASX |
| CMD details, CNA leader change & FY27 guidance reaffirmed | Nov 12, 2026 | Guidance | ASX |
| 2026 AGM Results | Oct 25, 2026 | Other filings | ASX |
| 2026 AGM Chair and CEO & President Addresses | Oct 25, 2026 | Other filings | ASX |
| Ceasing to be a substantial holder | Oct 22, 2026 | Ownership change notice | ASX |
| Notification of cessation of securities - COH | Oct 13, 2026 | Financing | ASX |
| Notification regarding unquoted securities - COH | Oct 13, 2026 | Other filings | ASX |
| Notification regarding unquoted securities - COH | Oct 13, 2026 | Other filings | ASX |
All 162 filings
Cap table
Built by 6ix from Cochlear Limited’s releases
- Common shares
- 65,398,917
- Fully diluted
- 65,398,917
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 65,398,917 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 65,398,917 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Chris Smith | Chief Executive Officer · Sep 11, 2025 – Nov 5, 2026 · Past |
Log in to ask 6ix AI your own questions about Cochlear Limited.